Biogen Alzheimer’s dope Aduhelm is the first new treatment for dementia approved by the FDA in decades, and it’s started a war over the brain drug pipeline.
Home / NEWS / Health Care / Biogen Alzheimer’s drug and the battle over dementia treatment of the future
Check Also
23andMe special committee again rejects CEO Wojcicki’s take-private offer
Anne Wojcicki, co-founder and chief boss officer of 23andme Inc., during the South by Southwest …